Product: MVASI (bevacizumab-awwb), Injection, For Intravenous Infusion After Dilution, 100 mg/4 ml, Single dose vial, Rx only, Manufactured by Amgen Inc. Thousand Oaks, CA 91320-1799, NDC 55513-0206-01
Reason for recall: Defective container: loose crimp defect, potential loss of container integrity.
Recall initiated: 20220502
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated